Art

J-GLOBAL ID：201802238996022060   Reference number：18A1012418

Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial

EGFR T790M変異陽性進行非小細胞肺癌の日本人患者におけるオシメルチニブ:AURA3試験

Author (10)： Akamatsu Hiroaki (Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan) ,  Katakami Nobuyuki (Institute of Biomedical Research and Innovation, Kobe, Japan) ,  Okamoto Isamu (Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan) ,  Kato Terufumi (Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan) ,  Kim Young Hak (Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Imamura Fumio (Osaka International Cancer Institute, Osaka, Japan) ,  Shinkai Masaharu (Yokohama City University Medical Center, Yokohama, Japan) ,  Hodge Rachel A. (AstraZeneca, Royston, Hertfordshire, UK) ,  Uchida Hirohiko (AstraZeneca, Osaka, Japan) ,  Hida Toyoaki (Aichi Cancer Center Hospital, Nagoya, Japan)
Material： Cancer Science (Web)  (Cancer Sci (Web))
Volume： 109  Issue： 6  Page： 1930-1938  Publication year： 2018 
JST Material Number： U0505A  ISSN： 1349-7006  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： phase 3 study ,...
Semi thesaurus term： genetic variation ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1012418&from=J-GLOBAL&jstjournalNo=U0505A") }}

Author keywords (5)： epidermal growth factor receptor ,  Japanese ,  mutation ,  non-small-cell lung cancer ,  tyrosine kinase

JST classification (3)： Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of respiratory system  (GI04000G)

Substance index (2)： Osimertinib ,  Pemetrexed

Terms in the title (7)： EGFR ,  変異 ,  進行非小細胞肺癌 ,  日本人 ,  患者 ,  オシメルチニブ ,  試験